BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38617783)

  • 21. Annual Change in Pulmonary Function and Clinical Characteristics of Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis: Over a 3-Year Follow-up.
    Kim YJ; Shin SH; Park JW; Kyung SY; Kang SM; Lee SP; Sung YM; Kim YK; Jeong SH
    Tuberc Respir Dis (Seoul); 2014 Jul; 77(1):18-23. PubMed ID: 25114699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, bronchoscopic, histopathologic, diagnostic imaging, and arterial oxygenation findings in West Highland White Terriers with idiopathic pulmonary fibrosis.
    Heikkilä HP; Lappalainen AK; Day MJ; Clercx C; Rajamäki MM
    J Vet Intern Med; 2011; 25(3):433-9. PubMed ID: 21366693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical induction of cough in Idiopathic Pulmonary Fibrosis.
    Jones RM; Hilldrup S; Hope-Gill BD; Eccles R; Harrison NK
    Cough; 2011 Apr; 7():2. PubMed ID: 21477349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study.
    Hirano C; Ohshimo S; Horimasu Y; Iwamoto H; Fujitaka K; Hamada H; Kohno N; Komoto D; Awai K; Shime N; Bonella F; Guzman J; Kühl H; Costabel U; Hattori N
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31771313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF).
    Enomoto N; Kusagaya H; Oyama Y; Kono M; Kaida Y; Kuroishi S; Hashimoto D; Fujisawa T; Yokomura K; Inui N; Nakamura Y; Suda T
    BMC Pulm Med; 2014 May; 14():91. PubMed ID: 24886550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extent of pulmonary fibrosis on high-resolution computed tomography is a prognostic factor in patients with pleuroparenchymal fibroelastosis.
    Namba M; Masuda T; Takao S; Terada H; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Nakashima T; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Awai K; Hattori N
    Respir Investig; 2020 Nov; 58(6):465-472. PubMed ID: 32762953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased volume of conducting airways in idiopathic pulmonary fibrosis is independent of disease severity: a volumetric capnography study.
    Plantier L; Debray MP; Estellat C; Flamant M; Roy C; Bancal C; Borie R; Israël-Biet D; Mal H; Crestani B; Delclaux C
    J Breath Res; 2016 Feb; 10(1):016005. PubMed ID: 26828240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis.
    Sugino K; Shimizu H; Nakamura Y; Isshiki T; Matsumoto K; Homma S
    J Thorac Dis; 2018 Feb; 10(2):899-908. PubMed ID: 29607163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remarkable response of non-small cell lung cancer to nintedanib treatment in a patient with idiopathic pulmonary fibrosis.
    Kai Y; Matsuda M; Fukuoka A; Hontsu S; Yamauchi M; Yoshikawa M; Muro S
    Thorac Cancer; 2021 May; 12(9):1457-1460. PubMed ID: 33742758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology and treatment of cough in idiopathic pulmonary fibrosis.
    Vigeland CL; Hughes AH; Horton MR
    Respir Med; 2017 Feb; 123():98-104. PubMed ID: 28137504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-life prevalence of progressive fibrosing interstitial lung diseases.
    Gagliardi M; Berg DV; Heylen CE; Koenig S; Hoton D; Tamirou F; Pieters T; Ghaye B; Froidure A
    Sci Rep; 2021 Dec; 11(1):23988. PubMed ID: 34907290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
    Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
    Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.
    Raghu G; Wells AU; Nicholson AG; Richeldi L; Flaherty KR; Le Maulf F; Stowasser S; Schlenker-Herceg R; Hansell DM
    Am J Respir Crit Care Med; 2017 Jan; 195(1):78-85. PubMed ID: 27331880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of idiopathic pulmonary fibrosis -associated cough. a case-control study.
    Saari E; Mononen M; Hasala H; Lätti A; Kaulamo J; Nurmi H; Kaarteenaho R; Purokivi M; Koskela HO
    BMC Pulm Med; 2023 May; 23(1):179. PubMed ID: 37221535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small Airway Reduction and Fibrosis Is an Early Pathologic Feature of Idiopathic Pulmonary Fibrosis.
    Ikezoe K; Hackett TL; Peterson S; Prins D; Hague CJ; Murphy D; LeDoux S; Chu F; Xu F; Cooper JD; Tanabe N; Ryerson CJ; Paré PD; Coxson HO; Colby TV; Hogg JC; Vasilescu DM
    Am J Respir Crit Care Med; 2021 Nov; 204(9):1048-1059. PubMed ID: 34343057
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Artificial Intelligence-based Technology for Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis.
    Handa T; Tanizawa K; Oguma T; Uozumi R; Watanabe K; Tanabe N; Niwamoto T; Shima H; Mori R; Nobashi TW; Sakamoto R; Kubo T; Kurosaki A; Kishi K; Nakamoto Y; Hirai T
    Ann Am Thorac Soc; 2022 Mar; 19(3):399-406. PubMed ID: 34410886
    [No Abstract]   [Full Text] [Related]  

  • 38. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge AT; Holland AE
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008351. PubMed ID: 26591003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.
    Salisbury ML; Gu T; Murray S; Gross BH; Chughtai A; Sayyouh M; Kazerooni EA; Myers JL; Lagstein A; Konopka KE; Belloli EA; Sheth JS; White ES; Holtze C; Martinez FJ; Flaherty KR
    Chest; 2019 Apr; 155(4):699-711. PubMed ID: 30243979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.
    Birring SS; Wijsenbeek MS; Agrawal S; van den Berg JWK; Stone H; Maher TM; Tutuncu A; Morice AH
    Lancet Respir Med; 2017 Oct; 5(10):806-815. PubMed ID: 28923239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.